No Detail Found!

Assessment of Antiviral combination therapy with Cephalosporin antibiotic for prevention of severe Influenza-A (H1N1)pdm09 infection associated secondary bacterial infection and other complications

Author(s)
Azfar Athar Ishaqui Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia; Department of Pharmacy, King Abdulaziz Hospital, Ministry of National Guard Health – Health Affairs, Alahsa, Saudi Arabia;King Abdullah International Medical Research Center, Alahsa, Saudi Arabia
Amer Hayat Khan Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia,Penang,Malaysia
Syed Azhar Syed Sulaiman Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia,Penang,Malaysia
Muhammad Alsultan Department of Pharmacy, King Abdulaziz Hospital, Ministry of National Guard Health - Health Affairs,Alahsa,Saudi Arabia;King Abdullah International Medical Research Center,Alahsa,Saudi Arabia
Irfanullah Khan Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia,Penang,Malaysia
Abstract
Secondary bacterial infection is considered as a major complication associated with severe Influenza-A (H1N1)pdm09 infection responsible for the mortalities and morbidities worldwide. Use of antibiotics in viral Influenza infection is still debatable. All the confirmed diagnosed hospitalized Influenza-A (H1N1)pdm09 infection patients fulfilling inclusion/exclusion criteria during the study period were divided into two groups based on drug therapy for initial 72 hours. Group-1 included those patients who received oral oseltamivir alone while Group-2 included patients who were initiated on oseltamivir in combination with empiric cephalosporin antibiotic within 6-8 hours after hospitalization. The patients of both groups were assessed for incidences of various complication associated with Influenza-A (H1N1)pdm09 infection. A total of 227 and 116 patients were enrolled for Group-1 and Group-2 respectively. The incidences of secondary bacterial infections were significantly less (P<0.05). Moreover, length of stay in hospitalization, need of ICU admission, multiple organ failure and need of respiratory support were also significantly less (P<0.05) for Group-2 patients. Majority of patients that suffered complications were unvaccinated and aged more than 50 years with multiple comorbidities. Among cephalosporins, cefuroxime was found to be least effective in prevention of Influenza associated complications. Early initiation of empiric antibiotic therapy in combination with oseltamivir can prevent complications associated with Influenza-A (H1N1)pdm09 infection especially in elderly and unvaccinated high risk patients. Different combinations of antibiotics and antiviral medications need to be analysed for the prevention of severe Influenza infection complications.
Publication Details
Page(s) 1763-1770
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: SUP4, Year: 2020

Request the full text from PASTIC

Keywords
Secondary bacterial infections, Oseltamivir, Cephalosporin, influenza a (H1N1)pdm09, complications of influenza infection
References
Ahn S,Kim WY,Kim SH,Hong S,Lim CM,Koh Y,Lim KS,Kim W .2011 .Role of procalcitonin and C‐reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia. Influenza. Other. Resp., 5(6) : 398-403.
America IDSo Influenza H1N1 .2009 .: frontline questions and expert opinion answers. , : .
Campigotto A,Mubareka S A .2015 .Influenzaassociated bacterial pneumonia; Managing and controlling infection on two fronts. Expert. Rev. AntiInfe., 13(1) : 55-68.
Chertow DS,Memoli MJ DS .2013 .Bacterial coinfection in influenza: A grand rounds review. Jama, 309(3) : 275-282.
Chong CP,Street PR .2008 .Pneumonia in the elderly: A review of the epidemiology, pathogenesis, microbiology, and clinical features. South. Med, 101(11) : 1141-1145.
Cuquemelle E,Soulis F,Villers D,Roche-Campo F,Somohano CA,Fartoukh M,Kouatchet A,Mourvillier B,Dellamonica J,Picard W .2011 .Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. J. Intensive. Care Med, 37(5) : 796-800.
Davey S .1999 .Removing obstacles to healthy development.. World Health Organization report on infectious diseases, : .
Engelmann I,Dubos F,Lobert P-E,Houssin C,Degas V,Sardet A,Decoster A,Dewilde A,Martinot A,Hober D A .2015 .Diagnosis of viral infections using myxovirus resistance protein A (MxA). Pediatrics, 135(4) : e985-e993.
Falsey AR,Becker KL,Swinburne AJ,Nylen ES,Formica MA,Hennessey PA,Criddle MM,Peterson DR,Baran A,Walsh EE .2013 .Bacterial complications of respiratory tract viral illness: A comprehensive evaluation. J. Infect., 208(3) : 432-441.
Gonzales R,Bartlett JG,Besser RE,Cooper RJ,Hickner JM,Hoffman JR,Sande MA .2001 .Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: Background, specific aims and methods. , 134(6) : 479-486.
Investigators AI .2009 .Critical care services and 2009 H1N1 influenza in Australia and New Zealand. New England Journal of Medicine, 361(20) : 1925-1934.
Janssens JP,Krause KH .2004 .Pneumonia in the very old. Lancet. Infect. Dis., 4(2) : 112-124.
Klein EY,Monteforte B,Gupta A,Jiang W,May L,Hsieh YH,Dugas A .2016 .The frequency of influenza and bacterial coinfection: a systematic review and meta analysis. Influenza. Other. Resp., 10(5) : 394-403.
Libster R,Bugna J,Coviello S,Hijano DR,Dunaiewsky M,Reynoso N,Cavalieri ML,Guglielmo MC,Areso MS,Gilligan T .2010 .Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1)pdm09 in Argentina. N. Engl. J. Med, 362(1) : 45-55.
Lim WS .2007 .Pandemic flu: Clinical management of patients with an influenza-like illness during an influenza pandemic. Thorax, 62(suppl 1) : 1-46.
Martín-Loeches I,Sanchez-Corral A,Diaz E,Granada RM,Zaragoza R,Villavicencio C,Albaya A,Cerdá E,Catalán RM,Luque P .2011 .Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A (H1N1)pdm09 virus. Chest, 139(3) : 555-562.
McCullers JA .2004 .Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J. Infec., 190(3) : 519-526.
Metlay JP,MacKenzie T,McCulloch C,Maselli J,Levin SK,Kersey A,Gonzales R,Investigators I .2007 .Cluster-randomized trial to improve antibiotic use for adults with acute respiratory infections treated in emergency departments. Ann. Emerg. Med, 50(3) : 221-230.
Morens DM,Taubenberger JK,Fauci AS .2008 .Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infec., 198(7) : 962-970.
Ng H,Narasaraju T,Phoon M,Sim M,Seet J,Chow VT .2012 .Doxycycline treatment attenuates acute lung injury in mice infected with virulent influenza H3N2 virus: involvement of matrix metalloproteinases. Exp. Mol. Pathol, 92(3) : 287-295.
Pasman L .2012 .The complication of coinfection. Yale. J. Biol. Med, 85(1) : 127.
Purcell K and Fergie J .2002 .Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch. Pediat. Adol. Med, 156(4) : 322-324.
Purcell K and Fergie J .2004 .Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection. Pediatr. Infect. Dis. J., 23(3) : 267-269.
Randolph AG,Vaughn F,Sullivan R,Rubinson L,Thompson BT,Yoon G,Smoot E,Rice TW,Loftis LL,Helfaer M .2011 .Critically ill children during the 2009-2010 influenza pandemic in the United States. , 128(6) : e1450-e1458.
Rice TW,Rubinson L,Uyeki TM,Vaughn FL,John BB,Miller III RR,Higgs E,Randolph AG,Smoot BE,Thompson BT .2012 .Critical illness from 2009 pandemic influenza A (H1N1)pdm09 virus and bacterial co-infection in the United States. Crit. Care Med, 40(5) : 1487.
Shiley KT,Lautenbach E,Lee I .2010 .The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics? Infect. Control Hosp. , 31(11) : 1177-1183.
Smith AM .2018 .Host pathogen kinetics during influenza infection and coinfection: insights from predictive modeling. Immunol. Rev., 285(1) : 97-112.
Smith AM,McCullers JA .2014 .Secondary bacterial infections in influenza virus infection pathogenesis. Curr. Top. Microbiol, 385 : 327-356.
Stupka JE,Mortensen EM,Anzueto A,Restrepo MI .2009 .Community-acquired pneumonia in elderly patients. J. Aging Health.,, 5(6) : 763-774.
0

Citations

0

Downloads

14

Views